NTRK1 and cancer: Of note, a preclinical study suggested that high expression of opioid receptor can activate the receptors that play critical roles in cancer progression or metastasis, including epidermal growth factor receptor, vascular endothelial growth factor tyrosine kinases receptor, platelet‐derived growth factor receptor, and mitogen‐activated protein kinase receptor.21, 22